HIMS

SEC source: 0000899243-21-003097 · doc4.xml · derivative · entry 2

O'Keefe Lynne Chou · CIK 0001837800 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Define Ventures Fund I, L.P.

Disclosed balance after: 881

Underlying: Class A Common Stock · 881 shares

Expires 2026-01-20

F3 · derivative.exercise_date: In connection with the Merger, the Reporting Person received warrants exercisable for shares of Class A Common Stock in exchange for Class A Common Stock of Hims, Inc.

SEC source: 0000899243-21-003097 · doc4.xml · nonDerivative · entry 1

O'Keefe Lynne Chou · CIK 0001837800 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Define Ventures Fund I, L.P.

Disclosed balance after: 157,639

F1 · price: In connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc., the Reporting Person received (i) 143,594 shares of Class A Common Stock of New Hims and (ii) 14,045 shares of restricted New Hims Class A Common Stock (the "Earn Out Shares") in exchange for 317,002 shares of Class A Common Stock of Hims, Inc. The Earn Out Shares vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the Earn Out Conditions are not met during the five years following closing (the "Earn Out Period"), then the unvested Earn Out Shares will be automatically forfeited.

F2 · price: (Continued from footnote 1) On the effective date of the Merger, the closing price of New Hims Class A Common Stock was $16.38 per share.

F8 · ownership.nature: Ms. Chou O'Keefe may be deemed a beneficial owner of the securities held by Define Ventures Fund I, L.P.

SEC source: 0000899243-21-003110 · doc4.xml · derivative · entry 6

Bard Alex · CIK 0001837803 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,485

Underlying: Class A Common Stock · 3,485 shares

Expires not disclosed

F7 · derivative.exercise_price: In connection with the Merger, the Reporting Person received additional New Hims RSUs representing a portion of the aggregate 16,000,000 shares of New Hims Class A Common Stock comprising the Earn Out shares (the "Earn Out RSUs").

F8 · derivative.exercise_date: The Earn Out RSUs were received in exchange for Legacy Hims RSUs. Subject to the satisfaction of a time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition as specified in Footnote 6 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out Conditions are not met during the RSU Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

F8 · derivative.expiration_date: The Earn Out RSUs were received in exchange for Legacy Hims RSUs. Subject to the satisfaction of a time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition as specified in Footnote 6 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out Conditions are not met during the RSU Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

SEC source: 0000899243-21-003110 · doc4.xml · derivative · entry 5

Bard Alex · CIK 0001837803 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,627

Underlying: Class A Common Stock · 35,627 shares

Expires not disclosed

F5 · derivative.exercise_price: In connection with the Merger, the Reporting Person received New Hims restricted stock units ("New Hims RSUs") in exchange for restricted stock units of Hims, Inc. ("Legacy Hims RSUs").

F6 · derivative.exercise_date: The New Hims RSUs were received in exchange for 78,651 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period commencing in March 2021, with 25% vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or following the one-year anniversary of the vesting commencement date and the remaining 75% of the New Hims RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with Him News. The New Hims RSU expires in January 2028.

F6 · derivative.expiration_date: The New Hims RSUs were received in exchange for 78,651 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period commencing in March 2021, with 25% vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or following the one-year anniversary of the vesting commencement date and the remaining 75% of the New Hims RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with Him News. The New Hims RSU expires in January 2028.

SEC source: 0000899243-21-003110 · doc4.xml · derivative · entry 4

Bard Alex · CIK 0001837803 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Redpoint Ventures VI, L.P.

Disclosed balance after: 56,307

Underlying: Class A Common Stock · 56,307 shares

Expires 2026-01-20

F4 · derivative.exercise_date: In connection with the Merger, the Reporting Person received warrants exercisable for shares of New Hims Class A Common Stock in exchange for Class A Common Stock of Hims, Inc.

F9 · ownership.nature: Alex Bard is one of several members of Redpoint Ventures VI, L.L.C., the general partner of Redpoint Ventures VI, L.P. ("RV VI"), and Redpoint Associates VI, L.L.C. ("RA VI"). Mr. Bard may be deemed a beneficial owner of the securities held by RV VI and RA VI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

SEC source: 0000899243-21-003110 · doc4.xml · derivative · entry 3

Bard Alex · CIK 0001837803 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Redpoint Associates VI, L.L.C.

Disclosed balance after: 1,739

Underlying: Class A Common Stock · 1,739 shares

Expires 2026-01-20

F4 · derivative.exercise_date: In connection with the Merger, the Reporting Person received warrants exercisable for shares of New Hims Class A Common Stock in exchange for Class A Common Stock of Hims, Inc.

F9 · ownership.nature: Alex Bard is one of several members of Redpoint Ventures VI, L.L.C., the general partner of Redpoint Ventures VI, L.P. ("RV VI"), and Redpoint Associates VI, L.L.C. ("RA VI"). Mr. Bard may be deemed a beneficial owner of the securities held by RV VI and RA VI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

SEC source: 0000899243-21-003110 · doc4.xml · nonDerivative · entry 2

Bard Alex · CIK 0001837803 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Redpoint Ventures VI, L.P.

Disclosed balance after: 10,069,213

F3 · price: In connection with the Merger, the Reporting Person received (i) 9,172,003 shares of Class A Common Stock of New Hims and (ii) 897,210 Earn Out Shares in exchange for 20,248,131 shares of Class A Common Stock of Hims, Inc. If the Earn Out Conditions are not met during the Earn Out Period, then the applicable Earn Out Shares shall be automatically forfeited. On the effective date of the Merger, the closing price of New Hims Class A Common Stock was $16.38 per share.

F9 · ownership.nature: Alex Bard is one of several members of Redpoint Ventures VI, L.L.C., the general partner of Redpoint Ventures VI, L.P. ("RV VI"), and Redpoint Associates VI, L.L.C. ("RA VI"). Mr. Bard may be deemed a beneficial owner of the securities held by RV VI and RA VI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

SEC source: 0000899243-21-003110 · doc4.xml · nonDerivative · entry 1

Bard Alex · CIK 0001837803 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Redpoint Associates VI, L.L.C.

Disclosed balance after: 311,414

F1 · price: In connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc., the Reporting Person received (i) 283,667 shares of Class A Common Stock of New Hims and (ii) 27,747 shares of restricted New Hims Class A Common Stock (the "Earn Out Shares") in exchange for 626,229 shares of Class A Common Stock of Hims, Inc. The Earn Out Shares vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the Earn Out Conditions are not met during the five years following closing (the "Earn Out Period"), then the unvested Earn Out Shares will be automatically forfeited.

F2 · price: (Continued from footnote 1) On the effective date of the Merger, the closing price of New Hims Class A Common Stock was $16.38 per share.

F9 · ownership.nature: Alex Bard is one of several members of Redpoint Ventures VI, L.L.C., the general partner of Redpoint Ventures VI, L.P. ("RV VI"), and Redpoint Associates VI, L.L.C. ("RA VI"). Mr. Bard may be deemed a beneficial owner of the securities held by RV VI and RA VI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

SEC source: 0000899243-21-003105 · doc4.xml · derivative · entry 6

Boughton Soleil · CIK 0001837817 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,184

Underlying: Class A Common Stock · 5,184 shares

Expires not disclosed

F8 · derivative.exercise_price: In connection with the Merger, the Reporting Person received additional New Hims RSUs representing a portion of the aggregate 16,000,000 shares of New Hims Class A Common Stock comprising the Earn Out shares (the "Earn Out RSUs").

F9 · derivative.exercise_date: The Earn Out RSUs were received in exchange for shares of Legacy Hims RSUs. Subject to the satisfaction of time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 7 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

F9 · derivative.expiration_date: The Earn Out RSUs were received in exchange for shares of Legacy Hims RSUs. Subject to the satisfaction of time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 7 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

SEC source: 0000899243-21-003105 · doc4.xml · derivative · entry 5

Boughton Soleil · CIK 0001837817 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,998

Underlying: Class A Common Stock · 52,998 shares

Expires not disclosed

F6 · derivative.exercise_price: In connection with the Merger, the Reporting Person received New Hims restricted stock units ("New Hims RSUs") in exchange for restricted stock units of Hims, Inc. ("Legacy Hims RSUs").

F7 · derivative.exercise_date: The New Hims RSUs were received in exchange for 117,000 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15, subject to the individual's continuous service. The RSU is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable RSU Agreement). The New Hims RSU expires in December 2027.

F7 · derivative.expiration_date: The New Hims RSUs were received in exchange for 117,000 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15, subject to the individual's continuous service. The RSU is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable RSU Agreement). The New Hims RSU expires in December 2027.

SEC source: 0000899243-21-003105 · doc4.xml · derivative · entry 4

Boughton Soleil · CIK 0001837817 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,450

Underlying: Class A Common Stock · 106,450 shares

Expires 2030-12-22

F5 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 235,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $4.26, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning December 16, 2020. The Stock Option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement).

SEC source: 0000899243-21-003105 · doc4.xml · derivative · entry 3

Boughton Soleil · CIK 0001837817 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,735

Underlying: Class A Common Stock · 339,735 shares

Expires 2030-05-12

F4 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 750,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning February 12, 2020. The Stock Option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement).

SEC source: 0000899243-21-003105 · doc4.xml · derivative · entry 2

Boughton Soleil · CIK 0001837817 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,085

Underlying: Class A Common Stock · 2,085 shares

Expires 2026-01-20

F3 · derivative.exercise_date: In connection with the Merger, the Reporting Person received warrants exercisable for shares of New Hims Class A Common Stock in exchange for Class A Common Stock of Hims, Inc.

SEC source: 0000899243-21-003105 · doc4.xml · nonDerivative · entry 1

Boughton Soleil · CIK 0001837817 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 367,735

F1 · price: In connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc., the Reporting Person received (i) 334,503 shares of Class A Common Stock of New Hims and (ii) 33,232 shares of restricted New Hims Class A Common Stock (the "Earn Out Shares") in exchange for 750,000 shares of Class A Common Stock of Hims, Inc. The Earn Out Shares vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the Earn Out Conditions are not met during the five years following closing (the "Earn Out Period"), then the unvested Earn Out Shares will be automatically forfeited.

F2 · price: (Continued From footnote 1) On the effective date of the Merger, the closing price of New Hims Class A Common Stock was $16.38 per share.

SEC source: 0000899243-21-003095 · doc4.xml · derivative · entry 4

Lee Spencer · CIK 0001839088 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,983

Underlying: Class A Common Stock · 12,983 shares

Expires not disclosed

F5 · derivative.exercise_price: In connection with the Merger, the Reporting Person received additional New Hims RSUs representing a portion of the aggregate 16,000,000 shares of New Hims Class A Common Stock comprising the Earn Out shares (the "Earn Out RSUs").

F6 · derivative.exercise_date: The Earn Out RSUs were received in exchange for Legacy Hims RSUs. Subject to the satisfaction of a time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition as specified in Footnote 4 above. Additionally, the Earn Out RSUs will vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the Earn Out Conditions are not met during the five years following the closing of the Merger, then the applicable Earn Out RSUs will be automatically forfeited.

F6 · derivative.expiration_date: The Earn Out RSUs were received in exchange for Legacy Hims RSUs. Subject to the satisfaction of a time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition as specified in Footnote 4 above. Additionally, the Earn Out RSUs will vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the Earn Out Conditions are not met during the five years following the closing of the Merger, then the applicable Earn Out RSUs will be automatically forfeited.

SEC source: 0000899243-21-003095 · doc4.xml · derivative · entry 3

Lee Spencer · CIK 0001839088 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,723

Underlying: Class A Common Stock · 132,723 shares

Expires not disclosed

F3 · derivative.exercise_price: In connection with the Merger, the Reporting Person received New Hims restricted stock units ("New Hims RSUs") in exchange for restricted stock units of Hims, Inc. ("Legacy Hims RSUs").

F4 · derivative.exercise_date: The New Hims RSUs were received in exchange for 293,000 Legacy Hims RSUs. The New Hims RSUs vest over 4 years of continuous service beginning in March 2021, with 6.25% of the New Hims RSUs vesting on each of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date to be the next occurring Company Quarterly Vesting Date that occurs on or after the vesting commencement date set forth above, subject to the individual's continuous service with New Hims. The New Hims RSU is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable RSU Agreement). The New Hims RSU expires in December 2027.

F4 · derivative.expiration_date: The New Hims RSUs were received in exchange for 293,000 Legacy Hims RSUs. The New Hims RSUs vest over 4 years of continuous service beginning in March 2021, with 6.25% of the New Hims RSUs vesting on each of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date to be the next occurring Company Quarterly Vesting Date that occurs on or after the vesting commencement date set forth above, subject to the individual's continuous service with New Hims. The New Hims RSU is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable RSU Agreement). The New Hims RSU expires in December 2027.

SEC source: 0000899243-21-003095 · doc4.xml · derivative · entry 2

Lee Spencer · CIK 0001839088 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,899

Underlying: Class A Common Stock · 265,899 shares

Expires 2030-12-22

F2 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 587,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $4.26, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning December 16, 2020. The Stock Option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement).

SEC source: 0000899243-21-003095 · doc4.xml · derivative · entry 1

Lee Spencer · CIK 0001839088 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,643,414

Underlying: Class A Common Stock · 1,643,414 shares

Expires 2029-05-01

F1 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,628,005 shares of Class A Common Stock of Hims, Inc., with an exercise price of $0.79, in connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc. 1/4 of the shares subject to the Stock Option vest on the 12 month anniversary of the vesting commencement date and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date, beginning March 4, 2019. The Stock Option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement).

SEC source: 0000899243-21-003106 · doc4.xml · derivative · entry 6

Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,614

Underlying: Class A Common Stock · 2,614 shares

Expires not disclosed

F7 · derivative.exercise_price: In connection with the Merger, the Reporting Person received additional New Hims RSUs representing a portion of the aggregate 16,000,000 shares of New Hims Class A Common Stock comprising the Earn Out shares (the "Earn Out RSUs").

F8 · derivative.exercise_date: The Earn Out RSUs were received in exchange for shares of Legacy Hims RSUs. Subject to the satisfaction of time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 6 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

F8 · derivative.expiration_date: The Earn Out RSUs were received in exchange for shares of Legacy Hims RSUs. Subject to the satisfaction of time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 6 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

SEC source: 0000899243-21-003106 · doc4.xml · derivative · entry 5

Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,725

Underlying: Class A Common Stock · 26,725 shares

Expires not disclosed

F5 · derivative.exercise_price: In connection with the Merger, the Reporting Person received New Hims restricted stock units ("New Hims RSUs") in exchange for restricted stock units of Hims, Inc. ("Legacy Hims RSUs").

F6 · derivative.exercise_date: The New Hims RSUs were received in exchange for 59,000 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15, subject to the individual's continuous service with the Company. The RSU is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable RSU Agreement).

F6 · derivative.expiration_date: The New Hims RSUs were received in exchange for 59,000 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15, subject to the individual's continuous service with the Company. The RSU is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable RSU Agreement).

SEC source: 0000899243-21-003106 · doc4.xml · derivative · entry 4

Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,192

Underlying: Class A Common Stock · 181,192 shares

Expires 2030-05-12

F4 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 400,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning February 12, 2020. The Stock Option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement).

SEC source: 0000899243-21-003106 · doc4.xml · derivative · entry 3

Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,245

Underlying: Class A Common Stock · 113,245 shares

Expires 2030-05-12

F3 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 250,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/4 of the shares subject to the Stock Option vest on the 12 month anniversary of the vesting commencement date and the balance of the shares shall vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date, beginning December 5, 2019.

SEC source: 0000899243-21-003106 · doc4.xml · derivative · entry 2

Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,947

Underlying: Class A Common Stock · 67,947 shares

Expires 2029-07-08

F2 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 150,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $0.79, in connection with the Merger. 1/4 of the shares subject to the Stock Option vest on the 12 month anniversary of the vesting commencement date and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date, beginning June 17, 2019.

SEC source: 0000899243-21-003106 · doc4.xml · derivative · entry 1

Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,998

Underlying: Class A Common Stock · 52,998 shares

Expires 2030-12-22

F1 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 117,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $4.26, in connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning December 16, 2020. The Stock Option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement).